Landec/LFCR

$6.06

-1.78%
-
1D1W1MYTD1YMAX

About Landec

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Ticker

LFCR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

James Hall

Employees

459

Headquarters

Chaska, United States

Landec Metrics

BasicAdvanced
$188.47M
Market cap
-
P/E ratio
-$3.29
EPS
1.02
Beta
-
Dividend rate
$188.47M
1.02447
$11.46
$3.69
195.74K
2.389
1.35
297.193
299.196
-1.05%
-24.32%
-153.69%
-41.13%
1.825
11.082
-7.19%
-304.63%
-13.59%

What the Analysts think about Landec

Analyst Ratings

Majority rating from 1 analysts.
Hold

Price Targets

Average projection from 2 analysts.
32.01% upside
High $10.00
Low $6.00
$6.06
Current price
$8.00
Average price target

Landec Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-139.21% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$25.5M
-7.61%
Net income
$-35.5M
-11.47%
Profit margin
-139.21%
-4.18%

Landec Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 137.33%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.32
-$0.24
-$0.22
-$0.89
-
Expected
-$0.14
-$0.04
-$0.13
-$0.38
-$0.23
Surprise
137.04%
500%
69.23%
137.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Landec stock?

Landec (LFCR) has a market cap of $188.47M as of April 13, 2024.

What is the P/E ratio for Landec stock?

The price to earnings (P/E) ratio for Landec (LFCR) stock is 0 as of April 13, 2024.

Does Landec stock pay dividends?

No, Landec (LFCR) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next Landec dividend payment date?

Landec (LFCR) stock does not pay dividends to its shareholders.

What is the beta indicator for Landec?

Landec (LFCR) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Landec stock price target?

The target price for Landec (LFCR) stock is $8, which is 32.01% above the current price of $6.06. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Landec stock

Buy or sell Landec stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing